Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaf Hoffmann

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Infection and Immunity|June 15, 2007
Pneumolysin causes neuronal cell death through mitochondrial damageJohann S Braun, Olaf Hoffmann, Miriam Schickhaus, et al.
Journal of Neuroimmunology|September 15, 2007
Toll-like receptor 2 mediates CNS injury in focal cerebral ischemiaSeija Lehnardt, Sabrina Lehmann, David Kaul, et al.
Diabetes/Metabolism Research and Reviews|June 6, 2003
Prevalence of psychiatric disorders in an onset cohort of adults with type 1 diabetesFrank Petrak, Jochen Hardt, Hans-Ulrich Wittchen, et al.
The Journal of Clinical Investigation|June 16, 2007
TRAIL limits excessive host immune responses in bacterial meningitisOlaf Hoffmann, Josef Priller, Timour Prozorovski, et al.
Digital Health|May 19, 2023
Development and usability testing of your MS questionnaire: A patient-based digital tool to monitor symptoms of multiple sclerosisGavin Giovannoni, Enrique Alvarez, Ellen Tutton, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 13, 2023
Tolerability of subcutaneous ofatumumab with long-term exposure in relapsing multiple sclerosisJohn Kramer, Ralf Linker, David Paling, et al.
BMC Neurology|March 5, 2020
Fingolimod after a first unilateral episode of acute optic neuritis (MOVING) - preliminary results from a randomized, rater-blind, active-controlled, phase 2 trialChristian Albert, Janine Mikolajczak, Anja Liekfeld, et al.
Zeitschrift Fur Psychosomatische Medizin Und Psychotherapie|July 23, 2019
Falk Leichsenring, Allan Abbass, Manfred Beutel, et al.
Journal of Critical Care|February 23, 2024
Brain death determination in patients with veno-arterial extracorporeal membrane oxygenation: A systematic study to address the Harlequin syndromeFarid Salih, Johann Lambeck, Albrecht Günther, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 13, 2020
High-dose vitamin D supplementation in multiple sclerosis - results from the randomized EVIDIMS (efficacy of vitamin D supplementation in multiple sclerosis) trialJan Dörr, Priscilla Bäcker-Koduah, Klaus-Dieter Wernecke, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Infection and Immunity|June 15, 2007
Pneumolysin causes neuronal cell death through mitochondrial damageJohann S Braun, Olaf Hoffmann, Miriam Schickhaus, et al.
Journal of Neuroimmunology|September 15, 2007
Toll-like receptor 2 mediates CNS injury in focal cerebral ischemiaSeija Lehnardt, Sabrina Lehmann, David Kaul, et al.
Diabetes/Metabolism Research and Reviews|June 6, 2003
Prevalence of psychiatric disorders in an onset cohort of adults with type 1 diabetesFrank Petrak, Jochen Hardt, Hans-Ulrich Wittchen, et al.
The Journal of Clinical Investigation|June 16, 2007
TRAIL limits excessive host immune responses in bacterial meningitisOlaf Hoffmann, Josef Priller, Timour Prozorovski, et al.
Digital Health|May 19, 2023
Development and usability testing of your MS questionnaire: A patient-based digital tool to monitor symptoms of multiple sclerosisGavin Giovannoni, Enrique Alvarez, Ellen Tutton, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 13, 2023
Tolerability of subcutaneous ofatumumab with long-term exposure in relapsing multiple sclerosisJohn Kramer, Ralf Linker, David Paling, et al.
BMC Neurology|March 5, 2020
Fingolimod after a first unilateral episode of acute optic neuritis (MOVING) - preliminary results from a randomized, rater-blind, active-controlled, phase 2 trialChristian Albert, Janine Mikolajczak, Anja Liekfeld, et al.
Zeitschrift Fur Psychosomatische Medizin Und Psychotherapie|July 23, 2019
Falk Leichsenring, Allan Abbass, Manfred Beutel, et al.
Journal of Critical Care|February 23, 2024
Brain death determination in patients with veno-arterial extracorporeal membrane oxygenation: A systematic study to address the Harlequin syndromeFarid Salih, Johann Lambeck, Albrecht Günther, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 13, 2020
High-dose vitamin D supplementation in multiple sclerosis - results from the randomized EVIDIMS (efficacy of vitamin D supplementation in multiple sclerosis) trialJan Dörr, Priscilla Bäcker-Koduah, Klaus-Dieter Wernecke, et al.
Pageof 5